Rum Mehmet, Ketenci Bulend, Kizilyel Fatih, Johnson Bahar Sarikamis, Celik Ulkan, Yildiz Berfin Ekin Gozukara, Ozhan Abdulkerim
University of Health Sciences Dr. Siyami Ersek Thoracic Cardiac and Vascular Surgery Hospital Department of Cardiovascular Surgery Istanbul Turkiye Department of Cardiovascular Surgery, Dr. Siyami Ersek Thoracic Cardiac and Vascular Surgery Hospital, University of Health Sciences, Istanbul, Turkiye.
University of Health Sciences Hamidiye Institute of Health Sciences Department of Medical Biology Istanbul Turkiye Department of Medical Biology, Hamidiye Institute of Health Sciences, University of Health Sciences, Istanbul, Turkiye.
Braz J Cardiovasc Surg. 2026 Jan 1;41(1). doi: 10.21470/1678-9741-2024-0218.
Type A aortic dissections are pathologies with high mortality rates. Although ascending aortic aneurysms are typically planned for elective surgery, they are significant conditions in cardiovascular surgery due to their potential to cause type A aortic dissection. This study, which is the first to examine sirtuin 1 (SIRT1) in human ascending aortic tissues, aims to elucidate the relationship between ascending aortic pathologies and the SIRT1 protein.
A case-control study was conducted using aortic tissues and demographic data from patients who underwent surgery for ascending aortic aneurysm and type A aortic dissection. Coronary artery bypass patients were selected as the control group. The groups were compared in terms of SIRT1 levels.
The study included a total of 46 patients (16 in the aneurysm group, 14 in the dissection group, and 16 in the control group). The SIRT1 protein level was the highest in the ascending aortic aneurysm group (214, interquartile range [IQR] 79 - 270), followed by the dissection group (172, IQR 148 - 224), and the lowest in the control group (104, IQR 78 - 123) (P = 0.014). SIRT1 level was found to be low in patients with coronary artery disease (P = 0.001), peripheral artery disease (P = 0.008), and hypertension (P = 0.023).
Type A aortic dissections are associated with elevated SIRT1 levels in the tissue. Systemic atherosclerotic diseases, such as coronary and peripheral artery diseases, are associated with decreased SIRT1 levels. There is also a relationship between hypertension and sirtuin1 levels.
A型主动脉夹层是死亡率很高的疾病。虽然升主动脉瘤通常计划进行择期手术,但由于其有引发A型主动脉夹层的可能性,所以在心血管外科中是重要病症。本研究首次在人类升主动脉组织中检测沉默调节蛋白1(SIRT1),旨在阐明升主动脉病变与SIRT1蛋白之间的关系。
采用接受升主动脉瘤和A型主动脉夹层手术患者的主动脉组织及人口统计学数据进行病例对照研究。选择冠状动脉搭桥患者作为对照组。比较两组的SIRT1水平。
该研究共纳入46例患者(动脉瘤组16例,夹层组14例,对照组16例)。升主动脉瘤组的SIRT1蛋白水平最高(214,四分位间距[IQR]79 - 270),其次是夹层组(172,IQR 148 - 224),对照组最低(104,IQR 78 - 123)(P = 0.014)。发现冠心病患者(P = 0.001)、外周动脉疾病患者(P = 0.008)和高血压患者(P = 0.023)的SIRT1水平较低。
A型主动脉夹层与组织中SIRT1水平升高有关。冠状动脉疾病和外周动脉疾病等全身性动脉粥样硬化疾病与SIRT1水平降低有关。高血压与沉默调节蛋白1水平之间也存在关联。